Blocking Type-1 Hypersensitivity Using Monoclonal Antibodies Against Human IgE

A new approach to treating and preventing Type-I hypersensitivity involves giving the person with allergies injections of monoclonal antibodies that have been made against the Fc portion of human IgE. This, in turn, blocks the attachment of the IgE to the Fc receptors on mast cells and basophils and the subsequent release of histamine and other inflammatory mediators by those cells upon subsequent exposure to allergen.

Doc Kaiser's Microbiology Home Page
Copyright © Gary E. Kaiser
All Rights Reserved
Updated: Nov., 2008
Please send comments and inquiries to Dr. Gary Kaiser